new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds

December 2007

You'll see new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds.

These will go beyond Avandia's and Actos's current black box warning about edema and heart failure.

The new warning will focus on whether Avandia increases the risk of ischemic events...angina and heart attacks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

people will become victims of medical identity theft
Diabetes new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds
Gastroenterology drugs surprise patients by causing esophageal pain
Men's Health possible hearing loss with the erectile dysfunction drugs (Viagra, etc)
Infectious Diseases Doribax (doripenem) is the fourth carbapenem antibiotic
Kidney Disease new formulation of Renagel called Renvela
Women's Health how to choose the right oral contraceptive
Women's Health stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy
Neurology & Pain what to use for low back pain
Psychiatry psychiatric problems and serious allergic reactions with modafinil (Provigil)
Rheumatology More patients will get hydroxychloroquine (Plaquenil, etc) for systemic lupus erythematosus
Supplements A controversy is brewing over the natural sweetener, stevia
Cardiology when it's better to use an ACE inhibitor or an angiotensin receptor blocker (ARB)
Practice End of year is a good time to reflect on trustworthy drug information that is relevant to practice